147 related articles for article (PubMed ID: 20423929)
41. Expression of activating transcription factor 5 (ATF5) is mediated by microRNA-520b-3p under diverse cellular stress in cancer cells.
Gaither KA; Watson CJW; Madarampalli B; Lazarus P
PLoS One; 2020; 15(6):e0225044. PubMed ID: 32603335
[TBL] [Abstract][Full Text] [Related]
42. The endoplasmic reticulum stress transducer BBF2H7 suppresses apoptosis by activating the ATF5-MCL1 pathway in growth plate cartilage.
Izumi S; Saito A; Kanemoto S; Kawasaki N; Asada R; Iwamoto H; Oki M; Miyagi H; Ochi M; Imaizumi K
J Biol Chem; 2012 Oct; 287(43):36190-200. PubMed ID: 22936798
[TBL] [Abstract][Full Text] [Related]
43. Co-expression of C/EBPγ and ATF5 in mouse vomeronasal sensory neurons during early postnatal development.
Nakano H; Iida Y; Murase T; Oyama N; Umemura M; Takahashi S; Takahashi Y
Cell Tissue Res; 2019 Dec; 378(3):427-440. PubMed ID: 31309319
[TBL] [Abstract][Full Text] [Related]
44. Advancements in Activating Transcription Factor 5 Function in Regulating Cell Stress and Survival.
Paerhati P; Liu J; Jin Z; Jakoš T; Zhu S; Qian L; Zhu J; Yuan Y
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806136
[TBL] [Abstract][Full Text] [Related]
45. Activating transcription factor 5 is required for mouse olfactory bulb development via interneuron.
Umemura M; Tsunematsu K; Shimizu YI; Nakano H; Takahashi S; Higashiura Y; Okabe M; Takahashi Y
Biosci Biotechnol Biochem; 2015; 79(7):1082-9. PubMed ID: 25704077
[TBL] [Abstract][Full Text] [Related]
46. The transcription factor ATF5: role in neurodevelopment and neural tumors.
Greene LA; Lee HY; Angelastro JM
J Neurochem; 2009 Jan; 108(1):11-22. PubMed ID: 19046351
[TBL] [Abstract][Full Text] [Related]
47. CHOP induces activating transcription factor 5 (ATF5) to trigger apoptosis in response to perturbations in protein homeostasis.
Teske BF; Fusakio ME; Zhou D; Shan J; McClintick JN; Kilberg MS; Wek RC
Mol Biol Cell; 2013 Aug; 24(15):2477-90. PubMed ID: 23761072
[TBL] [Abstract][Full Text] [Related]
48. ATF5 deficiency causes abnormal cortical development.
Umemura M; Kaneko Y; Tanabe R; Takahashi Y
Sci Rep; 2021 Mar; 11(1):7295. PubMed ID: 33790322
[TBL] [Abstract][Full Text] [Related]
49. Dominant-Negative ATF5 Compromises Cancer Cell Survival by Targeting CEBPB and CEBPD.
Sun X; Jefferson P; Zhou Q; Angelastro JM; Greene LA
Mol Cancer Res; 2020 Feb; 18(2):216-228. PubMed ID: 31676720
[TBL] [Abstract][Full Text] [Related]
50. Targeting ATF5 in Cancer.
Angelastro JM
Trends Cancer; 2017 Jul; 3(7):471-474. PubMed ID: 28718401
[TBL] [Abstract][Full Text] [Related]
51. BCL-2 is a downstream target of ATF5 that mediates the prosurvival function of ATF5 in a cell type-dependent manner.
Dluzen D; Li G; Tacelosky D; Moreau M; Liu DX
J Biol Chem; 2011 Mar; 286(9):7705-13. PubMed ID: 21212266
[TBL] [Abstract][Full Text] [Related]
52. Role of ATF5 in the invasive potential of diverse human cancer cell lines.
Nukuda A; Endoh H; Yasuda M; Mizutani T; Kawabata K; Haga H
Biochem Biophys Res Commun; 2016 Jun; 474(3):509-514. PubMed ID: 27125458
[TBL] [Abstract][Full Text] [Related]
53. Transcription factor ATF5 is required for terminal differentiation and survival of olfactory sensory neurons.
Wang SZ; Ou J; Zhu LJ; Green MR
Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18589-94. PubMed ID: 23090999
[TBL] [Abstract][Full Text] [Related]
54. HSP70 protein promotes survival of C6 and U87 glioma cells by inhibition of ATF5 degradation.
Li G; Xu Y; Guan D; Liu Z; Liu DX
J Biol Chem; 2011 Jun; 286(23):20251-9. PubMed ID: 21521685
[TBL] [Abstract][Full Text] [Related]
55. Protein kinase Cθ gene expression is oppositely regulated by GCN5 and EBF1 in immature B cells.
Kikuchi H; Nakayama M; Kuribayashi F; Imajoh-Ohmi S; Nishitoh H; Takami Y; Nakayama T
FEBS Lett; 2014 May; 588(9):1739-42. PubMed ID: 24657615
[TBL] [Abstract][Full Text] [Related]
56. A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications.
Sheng Z; Li L; Zhu LJ; Smith TW; Demers A; Ross AH; Moser RP; Green MR
Nat Med; 2010 Jun; 16(6):671-7. PubMed ID: 20495567
[TBL] [Abstract][Full Text] [Related]
57. The transcription factor ATF5 is widely expressed in carcinomas, and interference with its function selectively kills neoplastic, but not nontransformed, breast cell lines.
Monaco SE; Angelastro JM; Szabolcs M; Greene LA
Int J Cancer; 2007 May; 120(9):1883-90. PubMed ID: 17266024
[TBL] [Abstract][Full Text] [Related]
58. ATF5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemia.
Rousseau J; Gagné V; Labuda M; Beaubois C; Sinnett D; Laverdière C; Moghrabi A; Sallan SE; Silverman LB; Neuberg D; Kutok JL; Krajinovic M
Blood; 2011 Nov; 118(22):5883-90. PubMed ID: 21972289
[TBL] [Abstract][Full Text] [Related]
59. Requirement of activating transcription factor 5 for murine fetal liver erythropoiesis.
Zhang S; Chen JJ
Br J Haematol; 2020 Feb; 188(4):582-585. PubMed ID: 31524288
[TBL] [Abstract][Full Text] [Related]
60. Expression and targeting of transcription factor ATF5 in dog gliomas.
York D; Sproul CD; Chikere N; Dickinson PJ; Angelastro JM
Vet Comp Oncol; 2018 Mar; 16(1):102-107. PubMed ID: 28480569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
